Drug intelligence / Profile preview

collagen tripeptide

Development stage
Unknown
Lead developer
DolCas Biotech
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Oral, Topical
01

Overview

Collagen tripeptide is a highly bioavailable, low molecular weight peptide consisting of three amino acids—glycine, proline, and hydroxyproline—derived from the enzymatic hydrolysis of animal or marine collagen. It is designed to mimic the repeating unit found in natural collagen and is often referred to by its sequence (Gly-Pro-Hyp) or as Tripeptide-29. Collagen tripeptides are absorbed intact through specific intestinal receptors (PEPT1), allowing them to circulate in the bloodstream and reach target tissues such as skin and joints[6][8]. Mechanistically, they stimulate fibroblast activity, leading to increased synthesis of type I collagen in skin and connective tissue[6][10]. Clinical studies suggest that oral supplementation with collagen tripeptides can improve skin hydration, elasticity, reduce wrinkles, support joint health, and may aid bone strength[5][7][8]. These peptides are used primarily as dietary supplements for anti-aging skincare benefits but also have applications for joint support.

Brand names
Morikol
Other names
collagen peptideglycine-proline-hydroxyproline
02

Targets

PepT1/PepT2 (Peptide transporters 1/2)

Beyond the preview

Go deeper on collagen tripeptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on collagen tripeptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call